A Study of Golimumab in Participants With Active Psoriatic Arthritis

NCT02181673 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Psoriatic

Interventions

DRUG: Placebo
DRUG: Golimumab

Sponsor

Janssen Research & Development, LLC